SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-037172
Filing Date
2023-11-07
Accepted
2023-11-07 07:13:30
Documents
99
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 6-K adc-20230930.htm   iXBRL 6-K 218327
2 EX-99.1 adc-20230930_d2.htm   iXBRL EX-99.1 1263568
3 EX-99.2 adct-20230930x6kex992.htm EX-99.2 311681
4 EX-99.3 adct-20230930ex993.htm EX-99.3 200256
10 image_4.jpg GRAPHIC 20773
  Complete submission text file 0001628280-23-037172.txt   9112193

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20230930.xsd EX-101.SCH 92057
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20230930_cal.xml EX-101.CAL 83504
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20230930_def.xml EX-101.DEF 335367
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20230930_lab.xml EX-101.LAB 699131
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20230930_pre.xml EX-101.PRE 504631
93 EXTRACTED XBRL INSTANCE DOCUMENT adc-20230930_htm.xml XML 1614037
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 231381532
SIC: 2834 Pharmaceutical Preparations